Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/15351
|
| Title: | Precision gestational diabetes treatment: A systematic review and meta-analyses |
| Authors: | Chivers, SC;Clemmensen, C;Dabelea, D;Dawed, AY;Deutsch, AJ;Dickens, LT;DiMeglio, LA;Dudenhöffer-Pfeifer, M;Evans-Molina, C;Fernández-Balsells, MM;Fitipaldi, H;Fitzpatrick, SL;Gitelman, SE;Goodarzi, MO;Grieger, JA;Guasch-Ferré, M;Habibi, N;Hansen, T;Huang, C;Harris-Kawano, A;Ismail, HM;Hoag, B;Johnson, RK;Jones, AG;Koivula, RW;Leong, A;Leung, GKW;Libman, IM;Liu, K;Long, SA;Lowe, WL;Morton, RW;Motala, AA;Onengut-Gumuscu, S;Pankow, JS;Pathirana, M;Pazmino, S;Perez, D;Petrie, JR;Powe, CE;Quinteros, A;Jain, R;Ray, D;Ried-Larsen, M;Saeed, Z;Santhakumar, V;Kanbour, S;Sarkar, S;Monaco, GSF;Scholtens, DM;Selvin, E;Sheu, WH-H;Speake, C;Stanislawski, MA;Steenackers, N;Steck, AK;Stefan, N;Støy, J;Taylor, R;Tye, SC;Ukke, GG;Urazbayeva, M;Van der Schueren, B;Vatier, C;Wentworth, JM;Hannah, W;White, SL;Yu, G;Zhang, Y;Zhou, SJ;Beltrand, J;Polak, M;Aukrust, I;de Franco, E;Flanagan, SE;Maloney, KA;McGovern, A;Molnes, J;Nakabuye, M;Njølstad, PR;Pomares-Millan, H;Provenzano, M;Saint-Martin, C;Zhang, C;Zhu, Y;Auh, S;de Souza, R;Fawcett, AJ;Gruber, C;Mekonnen, EG;Mixter, E;Sherifali, D;Eckel, RH;Nolan, JJ;Philipson, LH;Brown, RJ;Billings, LK;Boyle, K;Costacou, T;Dennis, JM;Florez, JC;Gloyn, AL;Gomez, MF;Gottlieb, PA;Greeley, SAW;Griffin, K;Hattersley, AT;Hirsch, IB;Hivert, M-F;Hood, KK;Josefson, JL;Kwak, SH;Laffel, LM;Lim, SS;Loos, RJF;Ma, RCW;Mathieu, C;Mathioudakis, N;Meigs, JB;Misra, S;Mohan, V;Murphy, R;Oram, R;Owen, KR;Ozanne, SE;Pearson, ER;Perng, W;Pollin, TI;Pop-Busui, R;Pratley, RE;Redman, LM;Redondo, MJ;Reynolds, RM;Semple, RK;Sherr, JL;Sims, EK;Sweeting, A;Tuomi, T;Udler, MS;Vesco, KK;Vilsbøll, T;Wagner, R;Rich, SS;Franks, PW;Ada/Easd, P |
| Contributors: | Institute of Molecular and Genomic Medicine |
| Abstract: | Gestational Diabetes Mellitus (GDM) affects approximately 1 in 7 pregnancies globally. It is associated with short- and long-term risks for both mother and baby. Therefore, optimizing treatment to effectively treat the condition has wide-ranging beneficial effects. However, despite the known heterogeneity in GDM, treatment guidelines and approaches are generally standardized. We hypothesized that a precision medicine approach could be a tool for risk-stratification of women to streamline successful GDM management. With the relatively short timeframe available to treat GDM, commencing effective therapy earlier, with more rapid normalization of hyperglycaemia, could have benefits for both mother and fetus. |
| Date: | 2023-10-05 |
| Relation: | Communications Medicine. 2023 Oct 05;3:Article number 135. |
| Link to: | https://doi.org/10.1038/s43856-023-00371-0 |
| Appears in Collections: | [許惠恒] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| NMG2023101305.pdf | | 735Kb | Adobe PDF | 47 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
